NeuroSense featuring the VP R&D
“If you haven’t experienced failure, you may not be aiming high enough.”
NeuroSense featuring the Regulatory Affairs Director
“Plan ahead and tackle tasks early. Do things right the first time”
NeuroSense featuring the Scientific Project Manager
“Seeing how an individual living with ALS could benefit so much from the technology I helped create, I was inspired to dedicate myself to finding a remedy for ALS and other neurodegenerative diseases”.
NeuroSense featuring the CEO
“The most rewarding aspect of leading NeuroSense is hearing how we have improved people’s lives”
The Luckiest Man On Earth
“Today I consider myself the luckiest man on the face of the earth.” — Lou Gehrig Yankee stadium retirement speech, July 4, 1939.
Breaking The Paradigm – Novel Approaches To ALS Therapy
How are new medications created? How does an idea for a treatment lead to the development of a product? How do you choose the right target and optimal mechanisms of action?
Is There Only One ALS?
Motor neuron diseases (MNDs) are a debilitating subset of diseases causing progressive neuronal destruction and eventual loss of muscular function
The Trials And Tribulations Of ALS Drug Development
Amyotrophic lateral sclerosis (ALS) is a complex disease with multiple interacting pathologies, that presents itself differently in each patient
Embarking On A Path To Hope
If you’ve heard of ALS before, it’s probably because in 2014 you poured a bucket of ice-cold water all over yourself for the ALS ice bucket challenge.